Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid
- PMID: 15705891
Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid
Abstract
Through digital karyotyping of permanent medulloblastoma cell lines, we found that the homeobox gene OTX2 was amplified more than 10-fold in three cell lines. Gene expression analyses showed that OTX2 transcripts were present at high levels in 14 of 15 (93%) medulloblastomas with anaplastic histopathologic features. Knockdown of OTX2 expression by siRNAs inhibited medulloblastoma cell growth in vitro, whereas pharmacologic doses of all-trans retinoic acid repressed OTX2 expression and induced apoptosis only in medulloblastoma cell lines that expressed OTX2. These observations suggest that OTX2 is essential for the pathogenesis of anaplastic medulloblastomas and that these tumors may be amenable to therapy with all-trans-retinoic acid.
Similar articles
-
Genomic amplification of orthodenticle homologue 2 in medulloblastomas.Cancer Res. 2005 Feb 1;65(3):703-7. Cancer Res. 2005. PMID: 15705863
-
OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.J Neuropathol Exp Neurol. 2006 Feb;65(2):176-86. doi: 10.1097/01.jnen.0000199576.70923.8a. J Neuropathol Exp Neurol. 2006. PMID: 16462208
-
OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.Int J Oncol. 2015 Nov;47(5):1703-10. doi: 10.3892/ijo.2015.3179. Epub 2015 Sep 23. Int J Oncol. 2015. PMID: 26397460
-
Structural and gene expression abnormalities induced by retinoic acid in the forebrain.Reprod Toxicol. 1998 Mar-Apr;12(2):169-76. doi: 10.1016/s0890-6238(97)00151-2. Reprod Toxicol. 1998. PMID: 9535511 Review. No abstract available.
-
Downstream of Otx2, or how to get a head.Trends Genet. 2001 Nov;17(11):633-6. doi: 10.1016/s0168-9525(01)02418-0. Trends Genet. 2001. PMID: 11672863 Review.
Cited by
-
OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells.Cancer Res. 2012 Nov 15;72(22):5988-6001. doi: 10.1158/0008-5472.CAN-12-0614. Epub 2012 Sep 17. Cancer Res. 2012. PMID: 22986744 Free PMC article.
-
The clinical implications of medulloblastoma subgroups.Nat Rev Neurol. 2012 May 8;8(6):340-51. doi: 10.1038/nrneurol.2012.78. Nat Rev Neurol. 2012. PMID: 22565209 Review.
-
FOXG1 dysregulation is a frequent event in medulloblastoma.J Neurooncol. 2007 Nov;85(2):111-22. doi: 10.1007/s11060-007-9394-3. Epub 2007 May 24. J Neurooncol. 2007. PMID: 17522785
-
Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition.Sci Rep. 2023 Jan 23;13(1):1273. doi: 10.1038/s41598-023-27375-z. Sci Rep. 2023. PMID: 36690651 Free PMC article.
-
Digital karyotyping: an update of its applications in cancer.Mol Diagn Ther. 2006;10(4):231-7. doi: 10.1007/BF03256461. Mol Diagn Ther. 2006. PMID: 16884326
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials